reference/14608838

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14608838

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	5992
issn	1078-0432 1557-3265
issueIdentifier	16
pageRange	5984-5992
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	5984
bibliographicCitation	Hernandez-Ilizaliturri FJ, Reddy N, Holkova B, Ottman E, Czuczman MS. Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model. Clin Cancer Res. 2005 Aug 15;11(16):5984–92. doi: 10.1158/1078-0432.ccr-05-0577. PMID: 16115943.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2889f82b8081c04bc18042a83e7af128 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10e6cd35696278c094d672e080ee9732 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f36bc499010a3821f6cebf0d6a4b0dc2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6af5947ea911a89c3dba11270a851a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fff55eadbd3ae91f3dd00a058dacc701
date	2005-08-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16115943 https://doi.org/10.1158/1078-0432.ccr-05-0577
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265 https://portal.issn.org/resource/ISSN/1078-0432
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Immunomodulatory Drug CC-5013 or CC-4047 and Rituximab Enhance Antitumor Activity in a Severe Combined Immunodeficient Mouse Lymphoma Model
discusses	http://id.nlm.nih.gov/mesh/M0441603 http://id.nlm.nih.gov/mesh/M0006644 http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0479831 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0011157 http://id.nlm.nih.gov/mesh/M0028321 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0544940
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008228Q000188 http://id.nlm.nih.gov/mesh/D023041Q000379 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D013792Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D013792Q000494 http://id.nlm.nih.gov/mesh/D007694Q000378 http://id.nlm.nih.gov/mesh/D058846 http://id.nlm.nih.gov/mesh/D007694Q000187 http://id.nlm.nih.gov/mesh/D000911Q000494 http://id.nlm.nih.gov/mesh/D007694Q000473 http://id.nlm.nih.gov/mesh/D008228Q000473 http://id.nlm.nih.gov/mesh/D000077269 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D005434 http://id.nlm.nih.gov/mesh/D018951Q000032 http://id.nlm.nih.gov/mesh/D013792Q000031 http://id.nlm.nih.gov/mesh/D016513 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D007155Q000627 http://id.nlm.nih.gov/mesh/D008228Q000378 http://id.nlm.nih.gov/mesh/D004247Q000096 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D007155Q000494 http://id.nlm.nih.gov/mesh/D000069283
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134780 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9856 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129427475 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249267819 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432

Showing number of triples: 1 to 76 of 76.